Pramiconazole
Jump to navigation
Jump to search
This article needs additional citations for verification. (January 2021) |
Clinical data | |
---|---|
Routes of administration | By mouth |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C35H39F2N7O4 |
Molar mass | 659.739 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Pramiconazole is a triazole antifungal which was under development by Barrier Therapeutics for the treatment of acute skin and mucosal fungal infections but was never marketed.[1][2]
References
- ^ "Pramiconazole - AdisInsight".
- ^ Geria AN, Scheinfeld NS (September 2008). "Pramiconazole, a triazole compound for the treatment of fungal infections". IDrugs: The Investigational Drugs Journal. 11 (9): 661–70. PMID 18763217.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from January 2021
- All articles needing additional references
- Drugs not assigned an ATC code
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Multiple chemicals in Infobox drug
- Multiple chemicals in an infobox that need indexing
- Chemical articles with multiple PubChem CIDs
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Dioxolanes
- Imidazolidinones
- Isopropyl compounds
- Lanosterol 14α-demethylase inhibitors
- Organofluorides
- Phenol ethers
- Piperazines
- Phenylethanolamine ethers
- Triazole antifungals
- Ureas
- All stub articles
- Antiinfective agent stubs